http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060086818-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-13452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-1303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D497-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D497-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-20
filingDate 2005-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd7eec6b55be0ba2b1000d535090fb63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7484217ac393c5fe1f25df3fe92dbbc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a25274019bd93e10ed15f781f6c4adf
publicationDate 2006-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20060086818-A
titleOfInvention S type 2-substituted hydroxy-2-indolidinylbutyric acid ester compound and preparation method thereof
abstract S-substituted 2-substituted hydrides, useful as intermediates for preparing camptothecin derivatives having antitumor activity, including 2-ethylation of 2-substituted hydroxy-2-indolidinylacetic acid ester compound 1 Process for preparing oxy-2-indolidinylbutyric acid ester compound (2):n n n n n n n n n n Wherein R 0 is a residue of the nitrogen-containing fused heterocyclic carboxylic acid of the absolute configuration "R", wherein the nitrogen atom is protected, R 1 and R 2 are lower alkyl groups, and E is an ester residue. ,n n n n n n n n n n [Symbols are the same as the above definition].
priorityDate 1996-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466920233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467000741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466203997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466512957

Total number of triples: 37.